T cell trafficking and metabolism: Novel mechanisms and targets for immunomodulation

Current Opinion in Pharmacology

Volumn 12, Issue 4, 2012, Pages 452-457

  Mauro, C ^a   Fu, H ^a   Marelli Berg, F ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INSULIN; KRUPPEL LIKE FACTOR 2; L SELECTIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL METABOLISM; CELL MIGRATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; ENDOTHELIUM; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; MEMORY T LYMPHOCYTE; MINOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY;

ANIMALS; CELL MOVEMENT; HUMANS; IMMUNOMODULATION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES;

EID: 84865003917     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.02.018     Document Type: Review

References (42)

1. F.M. Marelli-Berg, L. Cannella, F. Dazzi, and V. Mirenda The highway code of T cell trafficking J Pathol 214 2008 179 189
2. S. Shetty, C.J. Weston, Y.H. Oo, N. Westerlund, Z. Stamataki, J. Youster, S.G. Hubscher, M. Salmi, S. Jalkanen, P.F. Lalor, and D.H. Adams Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium J Immunol 186 2011 4147 4155
3. + T cells J Immunol 162 1999 696 703
4. J.E. Greening, T.I. Tree, K.T. Kotowicz, A.G. van Halteren, B.O.N.J.K. Roep, and M. Peakman Processing and presentation of the islet autoantigen gad by vascular endothelial cells promotes transmigration of autoreactive T-cells Diabetes 52 2003 717 725
5. T.D. Manes, and J.S. Pober Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4(+) T cells J Immunol 180 2008 8386 8392
6. R.A. Sobel, B.W. Blanchette, A.K. Bhan, and R.B. Colvin The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration J. Immunol. 132 1984 2402 2407
7. A.Y. Savinov, F.S. Wong, and A.V. Chervonsky IFN-gamma affects homing of diabetogenic T cells J Immunol 167 2001 6637 6643
8. + T cells J Exp Med 197 2003 643 656
9. + T-lymphocyte transendothelial migration (diapedesis) in vivo Blood 103 2004 3111 3116
10. M.L. Alegre, K.A. Frauwirth, and C.B. Thompson T-cell regulation by CD28 and CTLA-4 Nat Rev Immunol 1 2001 220 228
11. Y. Shimizu, G.A. van Seventer, E. Ennis, W. Newman, K.J. Horgan, and S. Shaw Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion J Exp Med 175 1992 577 582
12. S.M. Turcovski-Corrales, R.G. Fenton, G. Peltz, and D.D. Taub CD28:B7 interactions promote T cell adhesion Eur J Immunol 25 1995 3087 3093
13. J.I. Zell, T. Zell, C.S. Warden, A.S. Chan, M.E. Cook, C.L. Dell, S.Wr. Hunt, and Y. Shimizu Regulation of beta 1-integrin-mediated cell adhesion by the CBL adaptor protein Curr Biol 8 1998 814 822
14. T. Zell, S.Wr. Hunt, J.L. Mobley, L.D. Finkelstein, and Y. Shimizu CD28-mediated up-regulation of beta 1-integrin adhesion involves phosphatidylinositol 3-kinase J Immunol 156 1996 883 886
15. T.T. Chang, C. Jabs, R.A. Sobel, V.K. Kuchroo, and A.H. Sharpe Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis J Exp Med 190 1999 733 740
16. A.M. Girvin, M.C. Dal Canto, L. Rhee, B. Salomon, A. Sharpe, J.A. Bluestone, and S.D. Miller A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade J Immunol 164 2000 136 143
17. B. Salomon, and J.A. Bluestone Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu Rev Immunol 19 2001 225 252
18. V. Mirenda, S.J. Jarmin, R. David, J. Dyson, D. Scott, I. Gu, R.I. Lechler, K. Okkenhaug, and F.M. Marelli-Berg Physiological and aberrant regulation of memory T cell trafficking by the costimulatory molecule CD28 Blood 109 2007 2968 2977
19. K. Okkenhaug, L. Wu, K.M. Garza, J. La Rose, W. Khoo, B. Odermatt, T.W. Mak, P.S. Ohashi, and R. Rottapel A point mutation in CD28 distinguishes proliferative signals from survival signals Nat Immunol 2 2001 325 332
20. S. Bromley, W.R. Burack, K.G. Johnson, K. Somersalo, T.N. Sims, C. Sumen, M.M. Davis, A.S. Shaw, P.M. Allen, and M.L. Dustin The immunological synapse Annu Rev Immunol 19 2001 375 396
21. L.S.K. Walker Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXCR-5 positive CD4 cells and germinal centers J Exp Med 190 1999 1115 1122
22. B. Wei, S. da Rocha Dias, H. Wang, and C.E. Rudd CTL-associated antigen-4 ligation induces rapid T cell polarization that depends on phosphatidylinositol 3-kinase, VAV-1, CDC42, and myosin light chain kinase 1 J Immunol 179 2007 400 408
23. H. Schneider, J. Downey, A. Smith, B.H. Zinselmeyer, C. Rush, J.M. Brewer, B. Wei, N. Hogg, P. Garside, and C.E. Rudd Reversal of the tcr stop signal by CTLA-4 Science 313 2006 1972 1975
24. R.G. Jones, and C.B. Thompson Revving the engine: signal transduction fuels T cell activation Immunity 27 2007 173 178
25. J.D. Powell, and G.M. Delgoffe The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism Immunity 33 2010 301 311
26. C. Peter, H. Waldmann, and S.P. Cobbold mTOR signalling and metabolic regulation of T cell differentiation Curr Opin Immunol 22 2010 655 661
27. R. Zoncu, A. Efeyan, and D.M. Sabatini mTOR: from growth signal integration to cancer, diabetes and ageing Nat Rev Mol Cell Biol 12 2011 21 35
28. Y. Zheng, G.M. Delgoffe, C.F. Meyer, W. Chan, and J.D. Powell Anergic T cells are metabolically anergic J Immunol 183 2009 6095 6101
29. A.D. Wells New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting J Immunol 182 2009 7331 7341
30. G.M. Delgoffe, T.P. Kole, Y. Zheng, P.E. Zarek, K.L. Matthews, B. Xiao, P.F. Worley, S.C. Kozma, and J.D. Powell The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment Immunity 30 2009 832 844
31. M. Battaglia, A. Stabilini, and M.G. Roncarolo Rapamycin selectively expands CD4+CD25+Foxp3+ regulatory T cells Blood 105 2005 4743 4748
32. K. Okkenhaug, and B. Vanhaesebroeck PI3K in lymphocyte development, differentiation and activation Nat Rev Immunol 3 2003 317 330
33. R.V. Parry, G.C. Whittaker, M. Sims, C.E. Edmead, M.J. Welham, and S.G. Ward Ligation of CD28 stimulates the formation of a multimeric signaling complex involving Grb-2-associated binder 2 (GAB2), src homology phosphatase-2, and phosphatidylinositol 3-kinase: evidence that negative regulation of CD28 signaling requires the GAB2 pleckstrin homology domain J Immunol 176 2006 594 602
34. S.G. Ward, and F.M. Marelli-Berg Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation Biochem J 15 2009 13 27
35. K. Okkenhaug, D.T. Patton, A. Bilancio, F. Garcon, W.C. Rowan, and B. Vanhaesebroeck The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of TH cells J Immunol 177 2006 5122 5128
36. S.J. Jarmin, R. David, L. Ma, J.-G. Chai, H. Dewchand, A. Takesono, A.J. Ridley, K. Okkenhaug, and F.M. Marelli-Berg Targeting T cell receptor-induced phosphoinositide-3-kinase p110delta activity prevents T cell localization to antigenic tissue J Clin Invest 118 2008 1154 1164
37. K. Reif, K. Okkenhaug, T. Sasaki, J.M. Penninger, B. Vanhaesebroeck, and J.G. Cyster Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing J Immunol 173 2004 2236 2240
38. Ying H, Fu H, Rose ML, McCormack AM, Sarathchandra P, Okkenhaug K, Marelli-Berg FM: Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110delta prevents chronic rejection of heart allografts. Plos One, in press.
39. L.V. Sinclair, D. Finlay, C. Feijoo, G.H. Cornish, A. Gray, A. Ager, K. Okkenhaug, T.J. Hagenbeek, H. Spits, and D.A. Cantrell Phosphatidylinositol-3- kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking Nat Immunol 9 2008 513 521
40. D. Finlay, and D.A. Cantrell Metabolism, migration and memory in cytotoxic T cells Nat Rev Immunol 11 2011 109 117
41. K.S. Peggs, S.A. Quezada, A.J. Korman, and J.P. Allison Principles and use of anti-CTLA4 antibody in human cancer immunotherapy Curr Opin Immunol 18 2006 206 213
42. G. Suntharalingam, M.R. Perry, S. Ward, S.J. Brett, A. Castello-Cortes, M.D. Brunner, and N. Panoskaltsis Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody tgn1412 N Engl J Med 355 2006 1018 1028